Dacarbazine Market Size, Share and Growth Analysis 2034
Dacarbazine, sometimes referred to as DTIC, is a chemotherapeutic drug used to treat several kinds of cancer. It belongs to the triazine family and is categorized as an alkylating agent. It functions by obstructing the proliferation of cancer cells. The medication accomplishes this by damaging DNA, which prevents these cells from replicating and repairing themselves, ultimately resulting in...
0 Comments 0 Shares 884 Views 0 Reviews